000 03885nam a22004935i 4500
001 978-3-642-24612-8
003 DE-He213
005 20140220083303.0
007 cr nn 008mamaa
008 120109s2012 gw | s |||| 0|eng d
020 _a9783642246128
_9978-3-642-24612-8
024 7 _a10.1007/978-3-642-24612-8
_2doi
050 4 _aRC321-580
072 7 _aPSAN
_2bicssc
072 7 _aMED057000
_2bisacsh
082 0 4 _a612.8
_223
100 1 _aStanford, Clare.
_eeditor.
245 1 0 _aBehavioral Neuroscience of Attention Deficit Hyperactivity Disorder and Its Treatment
_h[electronic resource] /
_cedited by Clare Stanford, Rosemary Tannock.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg,
_c2012.
300 _aXIV, 433p. 18 illus., 10 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aCurrent Topics in Behavioral Neurosciences,
_x1866-3370 ;
_v9
505 0 _aFrom the contents: ADHD in children and adults: diagnosis and prognosis -- ADHD: Volumetry, Motor, and Oculomotor Functions -- Neurodevelopmental abnormalities in ADHD -- Intra-individual Variability in ADHD and its Implications for Research of Causal Links -- Hypothalamic – pituitary - adrenocortical function in Attention Deficit / Hyperactivity Disorder -- Brain Processes in Discounting: Consequences of Adolescent Methylphenidate Exposure -- Attention Deficit Hyperactivity Disorder and Substance Use Disorders -- Linking ADHD, impulsivity and drug abuse: a neuropsychological perspective -- Obesity and ADHD:  clinical and neurobiological implications -- Face Processing in Attention Deficit/Hyperactivity Disorder -- Quantitative and molecular genetics of ADHD -- Rodent models of ADHD -- Rat Models of ADHD.-  Epigenetics: Genetics versus Life Experiences -- Sexual differentiation of the brain and ADHD:  What is a sex difference in prevalence telling us?- ADHD: Current and future therapeutics -- The Four Causes of ADHD: A Framework.
520 _aThe Behavioral Neuroscience of Attention Deficit Hyperactivity Disorder reviews the latest discoveries in research of ADHD.  There is a strong emphasis on translational science, with preclinical approaches suggesting new directions for development of new treatments.  Individual chapters describe how neuroimaging, neuroendocrine, genetic and behavioral studies use powerful research tools that are offering a completely new understanding of the factors that increase vulnerability to ADHD.  The clinical impact of co-morbid problems, especially obesity and substance misuse, are highlighted and explain what such problems can tell us about the etiology of ADHD, more generally.  Reviews of the pharmacology of established drug treatments for ADHD justify an exciting novel theory for their therapeutic actions and address questions about the effects of their long‑term use.  This volume is aimed at both clinicians and basic scientists, who are interested in ADHD, giving students and established researchers an overview of the current status of the field and insight into topics that will be prominent in the future.
650 0 _aMedicine.
650 0 _aNeurosciences.
650 0 _aPsychiatry.
650 0 _aPsychopharmacology.
650 1 4 _aBiomedicine.
650 2 4 _aNeurosciences.
650 2 4 _aPsychiatry.
650 2 4 _aPsychopharmacology.
700 1 _aTannock, Rosemary.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783642246111
830 0 _aCurrent Topics in Behavioral Neurosciences,
_x1866-3370 ;
_v9
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-642-24612-8
912 _aZDB-2-SBL
999 _c102307
_d102307